United Therapeutics Corp.
(NASDAQ : UTHR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 4.66%83.710.0%$530.92m
ICLRICON plc -0.03%246.492.8%$289.70m
VRXValeant Pharmaceuticals International, Inc. -6.54%27.7114.1%$163.05m
HZNPHorizon Therapeutics Plc -0.38%99.415.5%$111.54m
JAZZJazz Pharmaceuticals Plc -0.63%169.632.2%$86.44m
CTLTCatalent, Inc. 0.77%121.262.1%$79.03m
PRGOPerrigo Co. Plc -0.08%48.296.9%$49.62m
ENDPEndo International Plc -4.20%4.798.6%$44.39m
BHCBausch Health Cos., Inc. -6.48%27.730.0%$41.92m
ARGXargenx SE 0.85%311.380.0%$40.53m
UTHRUnited Therapeutics Corp. -0.88%178.2814.0%$38.47m
SAGESAGE Therapeutics, Inc. -2.56%42.267.6%$32.22m
NTECIntec Parent, Inc. -1.12%10.880.0%$31.43m
IRWDIronwood Pharmaceuticals, Inc. -3.26%12.849.6%$24.21m
AXSMAxsome Therapeutics, Inc. -0.95%49.841.9%$17.95m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.